Login to Your Account

More back and forth as Abbvie talks up benefits of Shire acquisiton

By Nuala Moran
Staff Writer

Wednesday, June 25, 2014
LONDON – Is it the tax break or the products? Abbvie Inc. launched its public campaign to acquire Shire plc for $47 billion, promising synergies in the pipelines and the opportunity to use its marketing heft to expand Shire's rare diseases and attention deficit hyperactivity disorder (ADHD) franchises.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription